ERBA Group showcases its latest technologies at MEDLAB

At the recently concluded MEDLAB expo, the ERBA Group, launched their latest hematology analyzers, H 360 and H 560. Designed for improving lab efficiency, these systems are paving the way for better healthcare outcomes in over 100 emerging market countries.

These latest additions are targeted at small to medium laboratories and complement the larger automatic Elite 580 hematology analyzer launched at MEDLAB 2018. The newly launched, H 360 3-part differential analyzer can run up to 60 samples/hour and requires only 9 microlitres of blood. The H 560 5-part differential analyzer also runs 60 samples/hour and requires only 15 microlitres, which is highly beneficial in pediatric cases. In both systems, interpretation of results is aided using an advanced 3D scattergram.

ERBA also displayed the latest version of its powerful Laura XL platform, which is a fully automated urine chemistry and sediment analyzer. Using digital microscopy and AI technology, it auto-recognises 16 urine sediment elements. Moreover, the photometric urine strip reader aids in precise determination of 10 analytes using ERBA’s standardised test strips DekaPHAN®.

The ERBA group also hosted an education session by Dr. Mir Majid Mossalaeie, Vice President of Iranian Association of Clinical Laboratory Doctors on the effectiveness of AMH ELISA test kits, which helps childless couples conceive though better estimation of ovarian age.  Dr. Mossalaeie commented on the high quality of ERBA’s AMH kit which is made by its US subsidiary, Calbiotech Inc., along with 200 other immunoassay products. The Director-General of Dubai Health Authority, His Excellency Humaid Al Quatami, visited the booth and was highly impressed by the wide range of technologies being offered by the group.